Application 062238
- Type
- ANDA
- Sponsor
- GLAXOSMITHKLINE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DYCILL | DICLOXACILLIN SODIUM | CAPSULE;ORAL | EQ 250MG BASE | No | No |
| 002 | DYCILL | DICLOXACILLIN SODIUM | CAPSULE;ORAL | EQ 500MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A062238-001 | DYCILL | DICLOXACILLIN SODIUM | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | ||
| A062238-002 | DYCILL | DICLOXACILLIN SODIUM | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-04-04 05:41 UTC | 2022-04 | A062238-001 | DYCILL | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A062238-002 | DYCILL | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A062238-001 | DYCILL | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A062238-002 | DYCILL | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A062238-001 | DYCILL | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A062238-002 | DYCILL | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A062238-001 | DYCILL | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A062238-002 | DYCILL | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A062238-001 | DYCILL | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A062238-002 | DYCILL | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A062238-001 | DYCILL | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A062238-002 | DYCILL | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A062238-001 | DYCILL | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A062238-002 | DYCILL | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A062238-001 | DYCILL | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A062238-002 | DYCILL | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A062238-001 | DYCILL | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A062238-002 | DYCILL | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A062238-001 | DYCILL | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A062238-002 | DYCILL | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A062238-001 | DYCILL | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A062238-002 | DYCILL | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A062238-001 | DYCILL | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A062238-002 | DYCILL | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A062238-001 | DYCILL | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A062238-002 | DYCILL | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A062238-001 | DYCILL | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A062238-002 | DYCILL | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A062238-001 | DYCILL | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A062238-002 | DYCILL | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A062238-001 | DYCILL | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A062238-002 | DYCILL | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A062238-001 | DYCILL | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A062238-002 | DYCILL | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A062238-001 | DYCILL | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A062238-002 | DYCILL | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A062238-001 | DYCILL | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | 053a50430f4f… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A062238-002 | DYCILL | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A062238-001 | DYCILL | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | 3bdfa0b2c4d7… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A062238-002 | DYCILL | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 | 3bdfa0b2c4d7… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dicloxacillin | DICLOXACILLIN SODIUM | Chartwell RX, LLC | 5d291f1b-6c9a-4e47-bc26-c1b8c0fd667c | 2026-11-09 | Warnings, Adverse reactions | DICLOXACILLIN SODIUM |
| Dicloxacillin Sodium | DICLOXACILLIN SODIUM | PD-Rx Pharmaceuticals, Inc. | 24e821aa-85b8-4f5a-aa13-83ff132952ca | 2026-11-09 | Warnings, Adverse reactions | DICLOXACILLIN SODIUM |
| DICLOXACILLIN SODIUM | DICLOXACILLIN SODIUM | Redpharm Drug | 58e6ee7a-8237-ec66-e063-6394a90a5cae | 2026-08-13 | Warnings, Adverse reactions | DICLOXACILLIN SODIUM |
| Dicloxacillin Sodium | DICLOXACILLIN SODIUM | PD-Rx Pharmaceuticals, Inc. | c17cd62d-ff5d-47ba-8673-3346c7f2365f | 2026-05-21 | Warnings, Adverse reactions | DICLOXACILLIN SODIUM |
| Dicloxacillin Sodium | DICLOXACILLIN SODIUM | PD-Rx Pharmaceuticals, Inc. | 9e2bbe03-44cb-45d1-acdb-b61d9016055e | 2025-10-20 | Warnings, Adverse reactions | DICLOXACILLIN SODIUM |
| Dicloxacillin Sodium | DICLOXACILLIN SODIUM | Bryant Ranch Prepack | 3e4842ec-773b-4aeb-b37d-1c4e3cf53424 | 2024-01-18 | Warnings, Adverse reactions | DICLOXACILLIN SODIUM |
| DICLOXACILLIN SODIUM | DICLOXACILLIN SODIUM | Aurobindo Pharma Limited | 9074b5a6-850c-4144-9097-bb21073ee54d | 2023-12-27 | Warnings, Adverse reactions | DICLOXACILLIN SODIUM |
| Dicloxacillin Sodium | DICLOXACILLIN SODIUM | Teva Pharmaceuticals USA, Inc. | 8478f242-c715-4984-ac1d-dc79dc28665e | 2022-06-22 | Warnings, Adverse reactions | DICLOXACILLIN SODIUM |
| Dicloxacillin Sodium | DICLOXACILLIN SODIUM | Asclemed USA, Inc. | a4174fda-68f7-4834-be58-dd6b167cf9f0 | 2020-11-14 | Warnings, Adverse reactions | DICLOXACILLIN SODIUM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.